Concepedia

Author

V. G. Kucheryanu

Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical SciencesORCID

Also Known As

V G KUCHERYANU, V G Kucheryanu, V Kucheryanu, V. G. Kucheryanu, V. Kucheryanu, V.G. Kucheryanu, Valerian G. Kucheryanu, Valerian Kucheryanu, Valeriayn G. Kucheryanu, Valery G. Kucheryanu

101

Publications

724

Citations

12

H-Index

41

Concepts

All Affiliations

Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical SciencesInstitute of Normal Physiology named after P.K. AnokhinUmeå UniversityCardiff UniversityKoltzov Institute of Developmental Biology
VG

About

V. G. Kucheryanu is an author at Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences specializing in medicine, neurology, and neuroscience.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

459

2

Neurology

9

9

334

3

Social Sciences

4

4

221

4

Immunology

3

3

164

5

Cell Biology

2

2

52

V. G. Kucheryanu

×

15

Publications

528

Citations

12

H-Index

YearCitations

Modeling of presymptomatic and symptomatic stages of parkinsonism in mice

M. V. Ugrumov, V. G. Kucheryanu, G. N. Kryzhanovsky,

Neuroscience

2011

121

Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression

M. A. Gruden, Robert D. E. Sewell, Kiran Yanamandra,

Journal of Neuroimmunology

2011

110

Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism

V. G. Kucheryanu, Nadezhda E. Vorobyeva, S. Georgieva,

Journal of the Neurological Sciences

2014

70

Correlation between Protective Immunity to α-Synuclein Aggregates, Oxidative Stress and Inflammation

M. A. Gruden, Kiran Yanamandra, V. G. Kucheryanu,

NeuroImmunoModulation

2012

38

Therapeutic Efficacy of the Neuroprotective Plant Adaptogen in Neurodegenerative Disease (Parkinson’s Disease as an Example)

I. A. Ivanova‐Smolenskaya, V. G. Kucheryanu, V. A. Il’enko

Bulletin of Experimental Biology and Medicine

2010

32

LIPOSOMES CONTAINING DOPAMINE ENTRAPPED IN RESPONSE TO TRANSMEMBRANE AMMONIUM SULFATE GRADIENT AS CARRIER SYSTEM FOR DOPAMINE DELIVERY INTO THE BRAIN OF PARKINSONIAN MICE

Igor V. Zhigaltsev, Alexander Kaplun, V. G. Kucheryanu,

Journal of Liposome Research

2001

25

Searching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage

V. E. Blokhin, M. R. Nodel, Ekaterina Pavlova,

International Journal of Molecular Sciences

2023

24

Effect of glutamate and antagonists of N-methyl-D-aspartate receptors on experimental parkinsonian syndrome in rats

V. G. Kucheryanu

Bulletin of Experimental Biology and Medicine

2000

21

Nasal inoculation with α-synuclein aggregates evokes rigidity, locomotor deficits and immunity to such misfolded species as well as dopamine

M. A. Gruden, Tatiana V. Davidova, Kiran Yanamandra,

Behavioural Brain Research

2013

16

Effect of complex phytoadaptogen on MPTP-induced parkinson's syndrome in mice

Eduard V. Bocharov, V. G. Kucheryanu, S. A. Belorustseva

Bulletin of Experimental Biology and Medicine

2006

15

Page 1